EU Delays Approval of Novavax's Revised COVID Vaccine

Reuters2023-10-16

European Union regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.

The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.

"As part of the ongoing review process, [the EMA] has additional questions, which we are answering expeditiously," Novavax told the Financial Times.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • 森田小狼
    2023-10-16
    森田小狼
    I'm just curious, who on earth is taking COVID shots now?
Leave a comment
1
1